Table 1.
SIR for cancer of patient with urolithiasis, 1987–2012.
| Cancer site | Kidney | Ureter | Mixed | Bladder | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| O | SIR | 95% CI | O | SIR | 95% CI | O | SIR | 95% CI | O | SIR | 95% CI | |||||
| Colon | 486 | 1.54 | 1.40 | 1.68 | 725 | 1.46 | 1.35 | 1.57 | 108 | 1.38 | 1.13 | 1.67 | 208 | 1.60 | 1.39 | 1.83 |
| Pancreas | 154 | 1.96 | 1.66 | 2.30 | 209 | 1.70 | 1.48 | 1.95 | 39 | 2.06 | 1.46 | 2.81 | 38 | 1.33 | 0.94 | 1.83 |
| Lung | 438 | 1.51 | 1.37 | 1.66 | 581 | 1.24 | 1.15 | 1.35 | 96 | 1.36 | 1.10 | 1.66 | 129 | 1.14 | 0.95 | 1.36 |
| Breast | 482 | 1.26 | 1.15 | 1.38 | 604 | 1.38 | 1.28 | 1.50 | 141 | 1.44 | 1.21 | 1.70 | 44 | 1.53 | 1.11 | 2.05 |
| Prostate | 1311 | 1.34 | 1.27 | 1.42 | 2416 | 1.37 | 1.32 | 1.43 | 331 | 1.30 | 1.16 | 1.45 | 874 | 1.74 | 1.62 | 1.86 |
| Kidney | 311 | 3.75 | 3.34 | 4.19 | 375 | 2.78 | 2.50 | 3.07 | 82 | 4.01 | 3.19 | 4.98 | 64 | 2.15 | 1.66 | 2.75 |
| Urinary bladder | 422 | 2.15 | 1.95 | 2.37 | 589 | 1.73 | 1.60 | 1.88 | 113 | 2.35 | 1.93 | 2.82 | 350 | 3.34 | 3.00 | 3.71 |
| Melanoma | 300 | 1.41 | 1.25 | 1.58 | 473 | 1.45 | 1.33 | 1.59 | 68 | 1.16 | 0.90 | 1.47 | 73 | 1.26 | 0.99 | 1.59 |
| Other sites | 2998 | 1.54 | 1.48 | 1.59 | 4223 | 1.42 | 1.38 | 1.46 | 762 | 1.51 | 1.40 | 1.62 | 986 | 1.41 | 1.33 | 1.51 |
| All | 6902 | 1.54 | 1.50 | 1.58 | 10195 | 1.44 | 1.42 | 1.47 | 1740 | 1.51 | 1.44 | 1.58 | 2766 | 1.63 | 1.57 | 1.70 |
Bold type: 95% CI does not include 1.00.
O = observed number of cases; SIR = standardized incidence ratio; CI = confidence interval.